Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Idan Shalev has a total of 190 co-authors. Here are the top co-authors by number of shared publications:

  • Laura Etzel

    Department of Biobehavioral Health, The Pennsylvania State University, University Park, PA 16802, USA

    13 shared publications
  • Qiaofeng Ye

    Department of Biobehavioral Health, the Pennsylvania State University, University Park, PA, USA

    13 shared publications
  • Laura Etzel

    Department of Biobehavioral Health, The Pennsylvania State University, University Park, PA, 16802, USA

    12 shared publications
  • Waylon J. Hastings

    Department of Psychiatry and Behavioral Sciences Tulane University School of Medicine New Orleans Louisiana USA

    11 shared publications
  • Abner T. Apsley

    National Science Foundation Science and Technology Center for Quantitative Cell Biology, Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA

    10 shared publications
  • Jennie G. Noll

    Department of Psychology, University of Rochester, Rochester, NY, 14627, USA

    10 shared publications

Latest Publications

  • Plasma amino acid fluctuations in response to acute psychosocial stress among healthy adults with and without early-life adversity

    by Qiaofeng Ye, Laura Etzel, Abner T. Apsley, Aaliya Ahamed, Christopher R. Chiaro, Amanda Davis, Waylon J. Hastings, John T. Kozlosky, Lauren Petri, Idan Shalev

  • Open Access

    Maternal biological aging from pregnancy through four years postpartum with disrupted recovery by subsequent pregnancy

    by Laura Etzel, Patricia Garrett-Peters, Qiaofeng Ye, Abner T. Apsley, Aaliya Ahamed, John T. Kozlosky, Christopher R. Chiaro, Lorrie Schmid, Victoria K. Lee, Cathi Propper, et al.


  • Saliva cell-free mitochondrial DNA (cf-mtDNA) as a dynamic biomarker of stress and emotion in daily life: Evidence from two independent repeated-measures studies

    by Lauren Petri, Sun Ah Lee, David Shire, Samantha Leonard, Alexander Behnke, Idan Shalev, Jody Greaney, Lacy Alexander, David M. Almeida, Martin Picard, et al.

  • Open Access

    Physiological Age and Homeostatic Dysregulation Following Child Maltreatment in Youth

    by Qiaofeng Ye, Abner T. Apsley, Laura Etzel, Waylon J. Hastings, Christopher R. Chiaro, Hannah M. C. Schreier, Eric D. Claus, Alan A. Cohen, Zachary Fisher, Christine M. Heim, et al.

    Child maltreatment has been associated with biological hallmarks of aging, including telomere shortening and epigenetic instability; however, its influence on physiological age and homeostatic dysregulation in early life remains unclear. The current study examined pediatric versions of physiological age and homeostatic dysregulation in children aged 8-13 with and without exposure to maltreatment. Maltreatment exposure was determined based on investigational records within 12 months prior to enrollment. Physiological measures were trained and validated utilizing external datasets — the National Health and Nutrition Examination Survey III and IV, respectively. Physiological age was computed using the Klemera-Doubal Method to indicate physiological developmental status. Homeostatic dysregulation level was computed as the Mahalanobis distance from an external reference group. 216 females and 245 males with a mean age of 11.4 years (SD 1.5) were included (76.6% White, 13.2% Black, and 13.0% Hispanic, 76.6% with maltreatment). Exposure to maltreatment was not associated with changes in physiological age but was associated with greater homeostatic dysregulation. Further analyses by maltreatment type and sex revealed that physical abuse was associated with greater homeostatic dysregulation, while sexual abuse was associated with delayed physiological development, specifically in males. Exposure to multiple types of maltreatment was associated with greater homeostatic dysregulation among males, but not among females. This study revealed that recent exposure to certain types of maltreatment may impair physiological development or regulation in children, with sex-specific patterns suggesting greater effects in males. Findings further indicate that physiological development composites in youth are sensitive to the impact of child maltreatment and can be incorporated in future work to evaluate the long-term sequelae of adverse exposures in pediatric populations. As the impact of maltreatment was only nominally significant after correction for multiple testing, validation work in other samples is needed.

  • From population science to the clinic? Limits of epigenetic clocks as personal biomarkers

    by Abner T. Apsley, Laura Etzel, Qiaofeng Ye, Idan Shalev

    Epigenetic clocks are machine-learning algorithms which use DNA methylation patterns to predict aging-related phenotypes, such as chronological age, composite indicators of health, time-to-death, and the pace of biological aging. These clocks have been instrumental at the population level in revealing how disease risk emerges from behavioral, environmental, and psychosocial factors, and how certain anti-aging interventions may alter those trajectories. Given the success of epigenetic clocks at the population level, it is reasonable to assume they might also hold value as individual-level biomarkers. We contend, however, that fundamental technical and biological properties of these algorithms prohibit their current use at the individual level. Technical concerns include methods of clock construction, sample collection and processing, data preprocessing, and computational implementations. Biological considerations include the nature of DNA methylation and its dynamics, variation across developmental periods, tissue specificity, and sensitivity to environmental/sociodemographic contexts. We show that clocks fail to meet common standards for clinical utility compared with established biomarkers, and that applying epigenetic clocks in individual-level decision making can be uninformative and potentially harmful. Finally, we argue that even if all technical and biological hurdles can be overcome, epigenetic clocks, as we currently understand them, should not be used to make individual-level decisions.


  • Evaluation of reproductive profiles, epigenetic aging, and mortality in post-menopausal women

    by Qiaofeng Ye, Aaliya Ahamed, Idan Shalev, Laura Etzel

    Evolutionary theories of aging indicate trade-offs between reproduction and longevity. Epigenetic clocks, such as PhenoAge, GrimAge, and DunedinPoAm, were designed to reflect biological age and be used as surrogates for healthspan and mortality. The current study investigated the connection between reproductive profiles, epigenetic aging, and mortality among post-menopausal women (N=770; 50-85 years of age) with data from the National Health and Nutrition Examination Survey across the United States. Using latent profile analysis, we identified four distinct reproductive profiles: high gravidity but average parity (Class 1); high gravidity and high parity (Class 2); premature menopause (Class 3); and an average profile (Class 4). Women of Class 3 had an accelerated pace of aging as indicated by DunedinPoAm, but not an older epigenetic age as measured by PhenoAge or GrimAge. The association was significant among women who had ever used female hormones (β = 0.521; 95% CI: 0.014-1.027). Women of Class 1 or 2 did not exhibit accelerated epigenetic aging. Women of Class 3 had higher mortality (HR = 1.40, 95% CI: 1.08-1.81), and 36.3% of the effect was mediated through accelerated DunedinPoAm. Findings suggest that women with reproductive profiles characterized by premature menopause may have altered epigenetic aging trajectories. Pace of aging may be more sensitive to the impact of reproductive profile variations than biological age as indicated by PhenoAge or GrimAge. Clinically monitoring the pace of biological aging among women with premature menopause and an appropriate application of hormone replacement therapy may minimize the negative consequence of accelerated biological aging and reduce premature mortality.


  • Open Access

    Maternal Biological Aging in Mid to Late Pregnancy and across Four Years Postpartum: Evidence for Postpartum Recovery and Disruption by Subsequent Pregnancy

    by Laura Etzel, Patricia Garrett-Peters, Qiaofeng Ye, Abner T. Apsley, Aaliya Ahamed, John Kozlosky, Chris Chairo, Lorrie Schmid, Victoria K. Lee, Cathi Propper, et al.

    Background: Pregnancy involves substantial physiological, metabolic, and immunologic adaptation, which may alter trajectories of maternal biological aging. While emerging evidence suggests that pregnancy may transiently accelerate biological aging followed by partial postpartum recovery, longitudinal studies capturing these dynamics, particularly across successive pregnancies, are limited. This study examined changes in maternal biological aging over nearly four years postpartum and assessed whether subsequent pregnancies disrupted recovery trajectories. Methods: Participants (N = 130; aged 18 to 41 years; 23% non-Hispanic Black, 61% non-Hispanic White) were followed longitudinally across pregnancy and nearly four years postpartum. Biological aging was assessed in saliva at up to three timepoints using four biomarkers: absolute telomere length via qPCR, epigenetic clocks (GrimAge2 and PhenoAge), and pace-of-aging (DunedinPACE). Generalized additive mixed models were used to estimate nonlinear change in biological aging across time, with spline terms differentiating early postpartum recovery and later changes moderated by subsequent pregnancy. Results: In non-interaction models, telomere length was stable in the early (∼ 9 months) postpartum period (b=0.49, SE=0.54, P =.36), while there was a trend towards deceleration in GrimAge2 (b = −2.01, SE = 1.06, P =.06) and a significant deceleration in pace of aging (DunedinPACE; b = −0.24, SE = .04, P <.001). In later postpartum (∼43 months), telomere length declined significantly (b = −0.81, SE = .37, P =.029), while both GrimAge2 and pace of aging stabilized. A subsequent pregnancy in the later postpartum period was independently associated with shorter telomere length (b = −0.78, SE = .36, P =.032), but not with epigenetic clocks. Time-by-late subsequent pregnancy status interaction models revealed that the acceleration in aging markers during the later postpartum period was more pronounced among women who became pregnant again, particularly for DunedinPACE, where a significant interaction (b = 0.20, SE = .07, P =.006) suggested that subsequent pregnancy disrupted the slowed pace of aging observed postpartum. Interaction terms for Time-by-late subsequent pregnancy predicting telomere length and GrimAge2 were directionally consistent with this pattern of slowed recovery but did not reach statistical significance. Associations for PhenoAge were consistent in direction with the other aging indices but did not reach significance in either non-interaction or interaction models. Conclusion: Pregnancy may function as a biological stressor that transiently accelerates maternal aging, while the postpartum period offers a potential window for recovery. However, subsequent pregnancies may disrupt this recovery process, compounding biological aging over time. These findings underscore the importance of postpartum recovery and interpregnancy intervals in shaping maternal aging trajectories and warrant further investigation in larger, more diverse samples with additional metabolic covariates.

  • Open Access

    Maternal telomere length and oxidative stress in pregnancy: cross-sectional analysis with an exploratory examination of systemic inflammation

    by Laura Etzel, Qiaofeng Ye, Abner T. Apsley, Chris Chiaro, Lauren E. Petri, John Kozlosky, Cathi Propper, Roger Mills-Koonce, Sarah J. Short, Patricia Garrett-Peters, et al.

    Telomere length (TL) is a marker of cellular aging associated with risk for age-related diseases and is known to be influenced by various factors, including oxidative stress and inflammation, in the contexts of stress and aging. The physiological demands of pregnancy may impact maternal TL, though research in this area is sparse. We tested oxidative stress and explored inflammation as predictors of maternal TL in a sample of women with normative pregnancies. Participants (N = 88, aged 18 to 46 years, 25% non-Hispanic Black, 65% non-Hispanic White) were recruited during their 2nd or 3rd trimester. TL was measured using saliva via qPCR as absolute TL. Oxidative stress was derived from principal component analysis of selected metabolites measured via urinary metabolomics. Inflammation was quantified as total IL-6 in serum. Hypotheses were tested with stepwise generalized linear models. Longer TL was predicted by higher oxidative stress (b = 0.20 ± 0.08; P =.019), controlling for maternal age, gestational age, race/ethnicity, maternal BMI, and income-to-needs ratio. In our exploratory analysis, longer TL was also predicted by higher IL-6 (b = 0.76 ± 0.20; P =.0003) controlling for covariates. There was no significant interaction between oxidative stress and inflammation predicting TL. Our findings suggest that in normative pregnancies, both oxidative stress and inflammation are independently associated with longer telomere length. Given that these associations are inconsistent with the role of oxidative stress and inflammation on telomere biology in non-pregnant samples, future work should aim to replicate these findings in both normal and high-risk pregnancies, explore mechanisms underlying these associations using longitudinal designs, and examine how these relationships influence maternal and fetal health.


  • Top Cited Papers
    Open Access

    Cross‐tissue comparison of epigenetic aging clocks in humans

    by Abner T. Apsley, Qiaofeng Ye, Avshalom Caspi, Christopher Chiaro, Laura Etzel, Waylon J. Hastings, Christine M. Heim, John Kozlosky, Jennie G. Noll, Hannah M. C. Schreier, et al.

    Epigenetic clocks are a common group of tools used to measure biological aging—the progressive deterioration of cells, tissues, and organs. Epigenetic clocks have been trained almost exclusively using blood‐based tissues, but there is growing interest in estimating epigenetic age using less‐invasive oral‐based tissues (i.e., buccal or saliva) in both research and commercial settings. However, differentiated cell types across body tissues exhibit unique DNA methylation landscapes and age‐related alterations to the DNA methylome. Applying epigenetic clocks derived from blood‐based tissues to estimate epigenetic age of oral‐based tissues may introduce biases. We tested the within‐person comparability of common epigenetic clocks across five tissue types: buccal epithelial, saliva, dry blood spots, buffy coat (i.e., leukocytes), and peripheral blood mononuclear cells. We tested 284 distinct tissue samples from 83 individuals aged 9–70 years. Overall, there were significant within‐person differences in epigenetic clock estimates from oral‐based versus blood‐based tissues, with average differences of almost 30 years observed in some age clocks. In addition, most epigenetic clock estimates of blood‐based tissues exhibited low correlation with estimates from oral‐based tissues despite controlling for cellular proportions and other technical factors. Notably, the Skin and Blood clock exhibited the greatest concordance across all tissue types, indicating its unique ability to estimate chronological age in oral‐ and blood‐based tissues. Our findings indicate that application of blood‐derived epigenetic clocks in oral‐based tissues may not yield comparable estimates of epigenetic age, highlighting the need for careful consideration of tissue type when estimating epigenetic age.


  • Open Access

    Parental age at birth, telomere length, and autism spectrum disorders in the UK Biobank cohort

    by Qiaofeng Ye, Abner T. Apsley, Waylon J. Hastings, Laura Etzel, Craig Newschaffer, Idan Shalev

    Older parental age at birth is associated with increased risk of autism spectrum disorders (ASD) in offspring. Independently, shorter telomere length (TL) has also been shown to be associated with ASD in children. However, older paternal age at birth, with or without controlling for maternal age, has been associated with longer TL, a seemingly contradictory finding. Here, we conducted a retrospective cohort study among participants in the UK Biobank to disentangle associations between leukocyte TL and ASD status in adults, and the potential moderation by parental age on adult offspring's TL. Participants with ASD diagnosis (N = 87) with a mean age of 46.0 (SD 4.4) years were matched to participants without ASD diagnosis (N = 870) based on age, sex, ethnicity, education, household income, and assessment center. No statistically significant differences were seen in TL between participants with and without ASD when parental age at birth was not considered. However, there was a significant interaction between ASD diagnostic status and parental age on participants' TL, such that older paternal or maternal age at birth was more strongly associated with longer TL in participants with ASD. This study suggests that the shortened TL observed in children with ASD in previous research may partially depend on parental age at birth. Future studies tracking TL attrition before ASD diagnosis are warranted to depict temporal associations and the interacting effects of parental age at birth and ASD status on TL across the lifespan.